Annette Paschen
German Cancer Research Center(DE)Düsseldorf University Hospital(DE)Essen University Hospital(DE)West German Heart and Vascular Center Essen(DE)Deutschen Konsortium für Translationale Krebsforschung(DE)Heinrich Heine University Düsseldorf(DE)University of Duisburg-Essen(DE)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Immune Cell Function and Interaction, T-cell and B-cell Immunology
Most-Cited Works
- → Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma(2019)1,066 cited
- → NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo(2009)330 cited
- → Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions(2017)243 cited
- → Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell–Activating Receptor NKp30(2014)203 cited
- → Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D(2011)184 cited
- → Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B(2009)